Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:KIN’

Biopharmaceutical, Bio-technology

13G Filing: Ariel Investments and Kindred Biosciences Inc. (KIN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 1 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Should You Buy Kindred Biosciences Inc (KIN)?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
Biotech Stocks 9

Kindred Biosciences, Inc. (KIN): Hedge Funds and Value Investors Are Crazy About It

Kindred Biosciences Inc (NASDAQ:KIN) is a tiny stock, yet managed to attract high profile hedge funds and value investors. Famed value investor Seth Klarman......(read more)
kuvasz, outdoor, breed, mammal, white, guardian, adult, pedigree, head, shepherd, flock, sheep, portrait, guarding, protection

Is Kindred Biosciences Inc (KIN) Going to Burn These Hedge Funds?

Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest......(read more)

Billionaire Seth Klarman’s Top 3 Micro-Cap Stock Picks ~ Bellatrix Exploration Ltd (BXE), Kindred Biosciences Inc (KIN) and Alliance One International, Inc. (AOI)

The world’s 11th largest hedge fund, Seth Klarman’s Baupost Group, recently filed its 13F with the Securities and Exchange Commission for the end......(read more)

Seth Klarman’s Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)

In two filings with the Securities and Exchange Commission, Baupost Group, a hedge fund managed by Seth Klarman, disclosed reducing its position in......(read more)